利用「虚拟胎儿」模型探索影响产前微阵列不确定发现分类与报告的因素——一项先导研究
本研究采用「虚拟胎儿」先导研究,由15名来自实验室、产前及胚胎植入前遗传检测(PGT)单元的医学遗传学家,对10个产前诊断的、大于1Mb、包含OMIM致病基因、遗传自健康父母的不确定意义拷贝数变异(CNVs)进行分类,并评估影响分类、报告义务及侵入性检测或PGT推荐的因素。结果显示CNVs多被分类为VUS(74.7%),分类为致病/可能致病的概率在缺失 vs 重复中更高(aOR 10.9,95%CI 1.55-76.9),且妇科专业遗传学家更高(aOR 4.9,95%CI 1.03-23.3);84.0%的受访者会报告CNVs,29.3%的CNVs被推荐侵入性检测,32.4%被推荐PGT。
要点
- 10个产前不确定CNVs中,74.7%被分类为VUS,10.7%为可能良性,8.7%为可能致病,6.0%为致病。
- 缺失 vs 重复分类为致病/可能致病的调整比值比为10.9(95%CI 1.55-76.9),妇科专业遗传学家为4.9(95%CI 1.03-23.3)。
- 84.0%的受访者会报告CNVs,29.3%的CNVs被推荐侵入性检测,32.4%被推荐PGT。
核心结论
- 影响CNV分类/报告的因素主要是剂量、家族表型、遗传学家专业与经验;该先导研究有助于开发临床共识和最佳管理算法。
研究设计与样本
- 「虚拟胎儿」先导研究,由15名来自实验室、产前和PGT单元的医学遗传学家对10个产前诊断的VUS(>1Mb,包含OMIM致病基因,遗传自健康父母)进行分类。
主要发现
- CNVs分类为可能良性10.7%、VUS 74.7%、可能致病8.7%、致病6.0%。
- 分类为致病/可能致病的调整比值比:缺失 vs 重复为10.9(95%CI 1.55-76.9),妇科专业遗传学家为4.9(95%CI 1.03-23.3)。
- 84.0%的受访者会报告CNVs,取决于分类和家族表型。
- 29.3%的CNVs被推荐侵入性检测,取决于分类和遗传学家专业。
- 32.4%的CNVs被推荐PGT,取决于分类、经验年数和家族表型(接受体外受精的患者为38.0%,其他为26.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Significant discrepancy exists between laboratories in classification and reporting of copy number variants (CNVs). Studies exploring factors affecting prenatal CNV management are rare. Our "virtual fetus" pilot study examines these factors. METHOD: Ten prenatally diagnosed CNVs of uncertain significance (VUS) > 1Mb, encompassing OMIM-morbid genes, inherited from healthy parents, were classified by 15 MD geneticists from laboratory, prenatal, and preimplantation genetic testing (PGT) units. Geneticists addressed factors affecting classification, obligation to report, and recommendation for invasive testing or PGT. RESULTS: CNVs were classified likely benign (10.7%), VUS (74.7%), likely pathogenic (8.7%), or pathogenic (6.0%). Classification discrepancy was higher for losses versus gains. Classifying pathogenic/likely pathogenic was more common for losses (adjusted odds ratio [aOR] 10.9, 95% CI 1.55-76.9), and geneticists specializing in gynecology (aOR 4.9, 95% CI 1.03-23.3). 84.0% of respondents would report CNVs, depending on classification and family phenotype. Invasive testing in pregnancies was recommended for 29.3% of CNVs, depending on the classification and geneticist's specialization. PGT was recommended for 32.4%, depending on classification, experience years, and family's phenotype (38.0% for patients undergoing in vitro fertilization irrespectively, 26.7% otherwise). CONCLUSION: Factors affecting CNV classification/reporting are mainly dosage, family phenotype, geneticist specialization and experience. Understanding factors from our pilot study may facilitate developing an algorithm for clinical consensus and optimal management.
引用
- Michaelson-Cohen R, Salzer LS, Brabbing-Goldstein D, et al. Exploring the factors affecting classification and reporting of uncertain prenatal microarray findings, using a "virtual fetus" model-a pilot study. Prenat Diagn. 2024. PMID: 38353311. doi:10.1002/pd.6535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。